Cost-Utility Analysis and Value-Based Pricing of Digital Therapeutics for Pulmonary Rehabilitation in Chronic Respiratory Disease: Economic Evaluation Based on a Randomized Controlled Trial

Hyeonjung Park   ^{1, 2 *} , BPharm ;   Minseol Jang   ^{1, 2 *} , PharmD ;   Daehyun Kim   ^{1, 2} , PharmD ;   Chul Kim   ³ , MD, PhD ;   Jun Hyeong Song   ³ , MSc, MD ;   Ju Hyun Oh   ⁴ , MD ;   Chin Kook Rhee   ⁵ , MD, PhD ;   Jae Ha Lee   ⁶ , MD, PhD ;   Hee-Eun Choi   ^{7, 8 *} , MSc, MD ;   Hae Sun Suh   ^{1, 2, 9 *} , MPharm, MA, PhD

¹ Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, Seoul, Republic of Korea

² Institute of Regulatory Innovation through Science (IRIS), Kyung Hee University, Seoul, Seoul, Republic of Korea

³ Inje University College of Medicine, Department of Rehabilitation Medicine, Inje University Sanggye Paik Hospital, Seoul, l, Republic of Korea

⁴ Ajou University School of Medicine, Department of Pulmonary and Critical Care Medicine, Ajou University Medical Center, Suwon, Republic of Korea

⁵ College of Medicine, The Catholic University of Korea, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary’s Hospital, Seoul, Republic of Korea

⁶ Inje University College of Medicine, Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Busan, Republic of Korea

⁷ Inje University College of Medicine, Department of Physical Medicine and Rehabilitation,Inje University Haeundae Paik Hospital, Busan, Republic of Korea

⁸ Emocog Inc., Seoul, Republic of Korea

⁹ College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea

*these authors contributed equally